UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 427

Sortiert nach

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis

Breast (Edinburgh), 2017-06, Vol.33, p.104-108

2017

Volltextzugriff (PDF)

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

British journal of cancer, 2014-03, Vol.110 (5), p.1133-1138

2014

Volltextzugriff (PDF)

Letrozole withdrawal response in locally advanced breast cancer

Annals of oncology, 2011-08, Vol.22 (8), p.1927-1928

2011

Volltextzugriff (PDF)

OR30 Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (pregnancy and fertility) trial

Breast (Edinburgh), 2014-11, Vol.23, p.S12-S12

2014

Volltextzugriff (PDF)

Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?

Annals of oncology, 2010-06, Vol.21 (6), p.1376-1377

2010

Volltextzugriff (PDF)

HM35 Role of temporary ovarian suppression obtained with GnRH analogue in reducing premature ovarian failure induced by chemotherapy in premenopausal cancer patients: a meta-analysis of randomized studies

Breast (Edinburgh), 2012-11, Vol.21, p.S13-S13

2012

Volltextzugriff (PDF)

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

The lancet oncology, 2022-12, Vol.23 (12), p.1571-1582

2022

Volltextzugriff (PDF)

226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study

Annals of oncology, 2020-09, Vol.31, p.S331-S331

2020

Volltextzugriff (PDF)

TP53 germline mutation testing in early onset breast cancer

Annals of oncology, 2016-09, Vol.27, p.iv71

2016

Volltextzugriff (PDF)

Concurrent versus sequential adjuvant chemo-endocrine therapy in early stage hormone receptor-positive breast cancer patients: a systematic review and meta-analysis

Annals of oncology, 2016-09, Vol.27, p.iv62

2016

Volltextzugriff (PDF)

Neoadjuvant therapy with FEC followed by weekly paclitaxel and concurrent trastuzumab in Her2 positive non operable breast cancer: a phase II study

Annals of oncology, 2016-09, Vol.27, p.iv70

2016

Volltextzugriff (PDF)

Dose-dence adjuvant chemotherapy in early breast cancer: the results of 15 years of follow-up

Annals of oncology, 2016-09, Vol.27, p.iv61

2016

Volltextzugriff (PDF)

Outcomes of hormone-responsive (HR+) HER2 negative (HER2-) metastatic breast cancer (MBC) patients (P) according to their starting first-line (1st) treatment (T): chemotherapy (CT) or hormonal therapy (HT)

Annals of oncology, 2015-10, Vol.26, p.vi11

2015

Volltextzugriff (PDF)

Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (PREgnancy and FERtility) trial

Annals of oncology, 2015-10, Vol.26, p.vi10

2015

Volltextzugriff (PDF)

Ovarian suppression with luteinizing hormone-releasing hormone agonists during chemotherapy as a strategy to preserve ovarian function and fertility in breast cancer patients: a systematic review and meta-analysis of randomized studies

Annals of oncology, 2015-10, Vol.26, p.vi2

2015

Volltextzugriff (PDF)

The value of hormone serum concentration to predict the gonadotoxic effect of chemotherapy and the efficacy of LHRH analogs as a strategy to reduce treatment-related premature ovarian failure in breast cancer

Annals of oncology, 2015-10, Vol.26, p.vi8

2015

Volltextzugriff (PDF)

Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients

Annals of oncology, 2015-10, Vol.26, p.vi1

2015

Volltextzugriff (PDF)

1621 - Fertility Preservation in Young Early Breast Cancer: Strategies and Patient Preferences

Annals of oncology, 2012-09, Vol.23, p.ix521-ix521

2012

Volltextzugriff (PDF)

1551PD - Role of Temporary Ovarian Suppression Obtained with GNRH Analog in Reducing Premature Ovarian Failure (POF) Induced By Chemotherapy in Premenopausal Cancer Patients: a Meta-Analysis of Randomized Studies

Annals of oncology, 2012-09, Vol.23, p.ix501-ix501

2012

Volltextzugriff (PDF)

Role of Temporary Ovarian Suppression Obtained with GNRH Analog in Reducing Premature Ovarian Failure (POF) Induced By Chemotherapy in Premenopausal Cancer Patients: a Meta-Analysis of Randomized Studies

Annals of oncology, 2012-09, Vol.23, p.ix501

2012

Volltextzugriff (PDF)

Fertility Preservation in Young Early Breast Cancer: Strategies and Patient Preferences

Annals of oncology, 2012-09, Vol.23, p.ix521

2012

Volltextzugriff (PDF)

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole super([starf)

British journal of cancer, 2014-03, Vol.110 (5), p.1133-1138

2014

Volltextzugriff (PDF)

Incidence of Hepatitis B and C Infections in Early Breast Cancer Patients and Impact on Systemic Treatments

Annals of oncology, 2012-09, Vol.23, p.ix454

2012

Volltextzugriff (PDF)

Effects of body mass index (BMI) on plasma levels of estrone sulfate (ES) in postmenopausal women with breast cancer (BC) during letrozole (L) treatment

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.515-515

2011

Volltextzugriff (PDF)

1 – 25 von 427

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(327)
Mit Volltextzugriff
(368)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(224)
Life Sciences & Biomedicine
(143)
Physical Sciences
(110)
Humans
(109)
Chemistry
(75)
Female
(64)
Biological And Medical Sciences
(61)
Chemistry, Analytical
(52)
Male
(49)
Fundamental And Applied Biological Sciences. Psychology
(41)
Adult
(39)
Middle Aged
(37)
Exact Sciences And Technology
(34)
Italy
(34)
Aged
(28)
Europe
(27)
Geology
(27)
Medical Sciences
(26)
Biochemistry & Molecular Biology
(24)
Cenozoic
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

Letrozole withdrawal response in locally advanced breast cancer

OR30 Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (pregnancy and fertility) trial

Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?

HM35 Role of temporary ovarian suppression obtained with GnRH analogue in reducing premature ovarian failure induced by chemotherapy in premenopausal cancer patients: a meta-analysis of randomized studies

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

TP53 germline mutation testing in early onset breast cancer

Concurrent versus sequential adjuvant chemo-endocrine therapy in early stage hormone receptor-positive breast cancer patients: a systematic review and meta-analysis

Neoadjuvant therapy with FEC followed by weekly paclitaxel and concurrent trastuzumab in Her2 positive non operable breast cancer: a phase II study

Dose-dence adjuvant chemotherapy in early breast cancer: the results of 15 years of follow-up

Outcomes of hormone-responsive (HR+) HER2 negative (HER2-) metastatic breast cancer (MBC) patients (P) according to their starting first-line (1st) treatment (T): chemotherapy (CT) or hormonal therapy (HT)

Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (PREgnancy and FERtility) trial

Ovarian suppression with luteinizing hormone-releasing hormone agonists during chemotherapy as a strategy to preserve ovarian function and fertility in breast cancer patients: a systematic review and meta-analysis of randomized studies

The value of hormone serum concentration to predict the gonadotoxic effect of chemotherapy and the efficacy of LHRH analogs as a strategy to reduce treatment-related premature ovarian failure in breast cancer

Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients

1621 - Fertility Preservation in Young Early Breast Cancer: Strategies and Patient Preferences

1551PD - Role of Temporary Ovarian Suppression Obtained with GNRH Analog in Reducing Premature Ovarian Failure (POF) Induced By Chemotherapy in Premenopausal Cancer Patients: a Meta-Analysis of Randomized Studies

Role of Temporary Ovarian Suppression Obtained with GNRH Analog in Reducing Premature Ovarian Failure (POF) Induced By Chemotherapy in Premenopausal Cancer Patients: a Meta-Analysis of Randomized Studies

Fertility Preservation in Young Early Breast Cancer: Strategies and Patient Preferences

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole super([starf)

Incidence of Hepatitis B and C Infections in Early Breast Cancer Patients and Impact on Systemic Treatments

Effects of body mass index (BMI) on plasma levels of estrone sulfate (ES) in postmenopausal women with breast cancer (BC) during letrozole (L) treatment

Suchergebnisse filtern